Vor Biopharma Stock Technical Analysis
| VOR Stock | USD 12.78 0.29 2.22% |
As of the 15th of February 2026, Vor Biopharma has the Coefficient Of Variation of (219,273), risk adjusted performance of 0.0088, and Variance of 103.23. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vor Biopharma, as well as the relationship between them. Please validate Vor Biopharma market risk adjusted performance and treynor ratio to decide if Vor Biopharma is priced more or less accurately, providing market reflects its prevalent price of 12.78 per share. Given that Vor Biopharma has information ratio of (0.01), we advise you to double-check Vor Biopharma's current market performance to make sure the company can sustain itself at a future point.
Vor Biopharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Vor, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to VorVor Biopharma's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Vor Biopharma Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 44.6 | Hold | 5 | Odds |
Most Vor analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Vor stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Vor Biopharma, talking to its executives and customers, or listening to Vor conference calls.
Can Biotechnology industry sustain growth momentum? Does Vor have expansion opportunities? Factors like these will boost the valuation of Vor Biopharma. If investors know Vor will grow in the future, the company's valuation will be higher. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Vor Biopharma demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Investors evaluate Vor Biopharma using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Vor Biopharma's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Vor Biopharma's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Vor Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vor Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Vor Biopharma's market price signifies the transaction level at which participants voluntarily complete trades.
Vor Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vor Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vor Biopharma.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Vor Biopharma on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Vor Biopharma or generate 0.0% return on investment in Vor Biopharma over 90 days. Vor Biopharma is related to or competes with Fate Therapeutics, Nkarta, Actuate Therapeutics, Alector, Forte Biosciences, PepGen, and Anixa Biosciences. Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell therapies for cancer patients More
Vor Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vor Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vor Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 47.66 | |||
| Value At Risk | (11.01) | |||
| Potential Upside | 16.2 |
Vor Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vor Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vor Biopharma's standard deviation. In reality, there are many statistical measures that can use Vor Biopharma historical prices to predict the future Vor Biopharma's volatility.| Risk Adjusted Performance | 0.0088 | |||
| Jensen Alpha | 0.0074 | |||
| Total Risk Alpha | (0.77) | |||
| Treynor Ratio | 0.0398 |
Vor Biopharma February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0088 | |||
| Market Risk Adjusted Performance | 0.0498 | |||
| Mean Deviation | 7.06 | |||
| Coefficient Of Variation | (219,273) | |||
| Standard Deviation | 10.16 | |||
| Variance | 103.23 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | 0.0074 | |||
| Total Risk Alpha | (0.77) | |||
| Treynor Ratio | 0.0398 | |||
| Maximum Drawdown | 47.66 | |||
| Value At Risk | (11.01) | |||
| Potential Upside | 16.2 | |||
| Skewness | (1.07) | |||
| Kurtosis | 6.87 |
Vor Biopharma Backtested Returns
Vor Biopharma appears to be somewhat reliable, given 3 months investment horizon. Vor Biopharma owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0864, which indicates the firm had a 0.0864 % return per unit of risk over the last 3 months. By inspecting Vor Biopharma's technical indicators, you can evaluate if the expected return of 0.73% is justified by implied risk. Please review Vor Biopharma's Variance of 103.23, coefficient of variation of (219,273), and Risk Adjusted Performance of 0.0088 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Vor Biopharma holds a performance score of 6. The entity has a beta of -0.37, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Vor Biopharma are expected to decrease at a much lower rate. During the bear market, Vor Biopharma is likely to outperform the market. Please check Vor Biopharma's value at risk and rate of daily change , to make a quick decision on whether Vor Biopharma's existing price patterns will revert.
Auto-correlation | -0.37 |
Poor reverse predictability
Vor Biopharma has poor reverse predictability. Overlapping area represents the amount of predictability between Vor Biopharma time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vor Biopharma price movement. The serial correlation of -0.37 indicates that just about 37.0% of current Vor Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.37 | |
| Spearman Rank Test | -0.25 | |
| Residual Average | 0.0 | |
| Price Variance | 2.97 |
Vor Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Vor Biopharma Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Vor Biopharma across different markets.
About Vor Biopharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Vor Biopharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Vor Biopharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Vor Biopharma price pattern first instead of the macroeconomic environment surrounding Vor Biopharma. By analyzing Vor Biopharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Vor Biopharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Vor Biopharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
Vor Biopharma February 15, 2026 Technical Indicators
Most technical analysis of Vor help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Vor from various momentum indicators to cycle indicators. When you analyze Vor charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0088 | |||
| Market Risk Adjusted Performance | 0.0498 | |||
| Mean Deviation | 7.06 | |||
| Coefficient Of Variation | (219,273) | |||
| Standard Deviation | 10.16 | |||
| Variance | 103.23 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | 0.0074 | |||
| Total Risk Alpha | (0.77) | |||
| Treynor Ratio | 0.0398 | |||
| Maximum Drawdown | 47.66 | |||
| Value At Risk | (11.01) | |||
| Potential Upside | 16.2 | |||
| Skewness | (1.07) | |||
| Kurtosis | 6.87 |
Vor Biopharma February 15, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Vor stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.07 | ||
| Daily Balance Of Power | (0.33) | ||
| Rate Of Daily Change | 0.98 | ||
| Day Median Price | 13.04 | ||
| Day Typical Price | 12.95 | ||
| Price Action Indicator | (0.41) | ||
| Market Facilitation Index | 0.88 |
Additional Tools for Vor Stock Analysis
When running Vor Biopharma's price analysis, check to measure Vor Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vor Biopharma is operating at the current time. Most of Vor Biopharma's value examination focuses on studying past and present price action to predict the probability of Vor Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vor Biopharma's price. Additionally, you may evaluate how the addition of Vor Biopharma to your portfolios can decrease your overall portfolio volatility.